Akari Therapeutics Plc [AKTX]

Source: 

Company Overview

Akari Therapeutics Plc is a clinical-stage biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases involving the complement component 5 (“C5”) and leukotriene B4 (“LTB4”) pathways.